作者: Hidde L. Ploegh , Richard J. Riese , Harold A. Chapman , Matthew S. Bogyo , Paula R. Bryant
DOI:
关键词:
摘要: Methods and products for suppressing a class II MHC-restricted immune response in mammal, or mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from MHC/invariant complexes, thereby reducing the competency of MHC molecules binding antigenic peptides, presentation peptides molecules, responses. may be employed treatment autoimmune diseases, allergic responses, organ tissue graft rejection. New pharmaceutical therapeutic compositions which peptide-based inhibitors also